人工多能性幹細胞(iPS細胞)の世界市場は、2023年の34億ドルから2028年末までに52億ドルに達し、2023年から2028年までの年平均成長率(CAGR)は9.1%で成長すると予想されます。
						目次
						
	Chapter- 1: Introduction
	
	Study Goals and Objectives
	Reasons for Doing This Study
	Scope of Report
	What's New in This Update?
	Methodology
	Information Sources
	Geographic Breakdown
	Segmentation Breakdown
	Chapter- 2: Summary and Highlights
	
	Market Outlook
	Market Summary
	Chapter- 3: Market Overview
	
	Introduction
	Chapter- 4: Market Dynamics
	
	Market Drivers
	Use of iPSCs in Precision Medicine
	Chapter- 5: Induced Pluripotent Stem Cell Applications
	
	Academic Research
	Pharmaco-toxicological Screening
	Drug Discovery and Development
	Disease Modeling
	Tissue Engineering
	Cell Therapy
	Emerging Technologies
	Chapter- 6: Induced Pluripotent Stem Cell Market Segmentation and Forecast
	
	Market Overview
	U.S.
	Europe
	Asia-Pacific
	Generation of Induced Pluripotent Stem Cells
	Application-based Market Overview
	Induced Pluripotent Stem Cells Product Market
	Induced Pluripotent Stem Cell-derived Tissue Cell Market
	Induced Pluripotent Stem Cells and Their Derivative Cell Market, by Species
	Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
	Market for Induced Pluripotent Stem Cell-derived Cells, by Application
	Market for Induced Pluripotent Stem Cells, by Product Function
	Market for Induced Pluripotent Stem Cells, by End Use
	Chapter- 7: Induced Pluripotent Stem Cells Research Application Market
	
	Induced Pluripotent Stem Cells Research Product Types
	Major Players
	Market Shares and Projections
	Chapter- 8: Induced Pluripotent Stem Cell Contract Service Market
	
	Induced Pluripotent Stem Cell Contract Service Types
	Major Players
	Market Shares and Projections
	Chapter- 9: Clinical Application Market Trend Analysis
	
	Clinical Trials
	Driving Forces
	Limiting Factors
	Chapter- 10: Competitive Landscape
	
	Mergers and Acquisitions
	Strategic Alliances
	Chapter- 11: Company Profiles
	
	ADDGENE
	ALLELE BIOTECHNOLOGY AND PHARMACEUTICALS INC.
	ALSTEM
	APPLIED BIOLOGICAL MATERIALS INC. (ABM)
	APPLIED STEMCELL INC.
	ATCC
	AXOL BIOSCIENCE LTD.
	BIO-TECHNE CORP.
	BLUEROCK THERAPEUTICS
	BRISTOL MYERS SQUIBB (IPIERIAN)
	CELL SIGNALING TECHNOLOGY (CST)
	CORNING INC.
	CREATIVE BIOARRAYY
	FATE THERAPEUTICS
	FUJIFILM CELLULAR DYNAMICS INC. (FCDI)
	GENECOPOEIA INC.
	GENTARGET INC.
	ID PHARMA CO. LTD.
	INVIVOGEN
	LONZA GROUP LTD.
	MEGAKARYON CORP.
	MERCK KGAA
	NCARDIA
	NEWCELLS BIOTECH
	PEPROTECH INC.
	PLASTICELL LTD.
	PROMEGA CORP.
	PROMOCELL GMBH
	QIAGEN NV
	REPROCELL INC.
	SCIENCELL RESEARCH LABORATORIES
	STEMCELL TECHNOLOGIES
	SYSTEM BIOSCIENCES INC.
	TAKARA BIO USA INC. (CLONTECH LABORATORIES)
	THERMO FISHER SCIENTIFIC
	VERTEX PHARMACEUTICALS INC.
	WAISMAN BIOMANUFACTURING
	Chapter- 12: Appendix: Acronyms
	
	Table 33 : Acronyms Used in the iPSCs Industry